Drugs / mRNA-1230
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05585632 | Oct 2022 → Feb 2024 | Orthocoronavirinae infectious disease, influenza, respiratory syncytial virus infectious disease | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1230 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05585632 ↗ |